REFRACTORY NEUROBLASTOMA
Clinical trials for REFRACTORY NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double immune attack: new cell combo targets tough childhood cancers
Disease control Not yet recruitingThis early-phase study tests a new combination of two different immune cells—NK cells and CAR-T cells—for children and young adults with neuroblastoma or osteosarcoma that has returned or not responded to standard treatments. The NK cells are designed to help the CAR-T cells work…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
New hope for kids with tough neuroblastoma: drug combo trial opens
Disease control Not yet recruitingThis study tests adding a new drug, iberdomide, to standard chemoimmunotherapy for children and young adults (ages 1-30) whose neuroblastoma has returned, not responded, or worsened after prior treatment. The goal is to see if the combination is safe and works better at controlli…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC